inSili

inSili.com offers an elite source of intellectual property and unique expertise for innovative pharmaceutical and biotechnological research.

inSili.com offers an elite source of intellectual property and unique expertise for innovative pharmaceutical and biotechnological research and development. They provide know-how and world-leading technology services for virtual screening of pharmacologically active molecular agents. Their clients are among the world's top pharmaceutical, chemical, biotechnology and cosmeceutical enterprises. Founded in 2013 as an ETH spin-off company, inSili.com's exclusive technology platform, strong track record and solid partnerships enable a rennaissance of small-molecule drug discovery and provide the foundation for custom-tailored medicines of the future.